Upside – $BKYI +76% (no clear fresh catalyst identified; unusually large, high-volume premarket move) – $SSTI +51% (agrees to be acquired for $8.00 cash plus a contingent-value right worth up to another $3.00 per share) – $SANG +39% (agrees to a $204M cash-and-stock takeover at an indicated 47% premium) – $SMMT +18% ($2B strategic equity …
Read in context ›Summit Therapeutics Stock (SMMT)
Track Summit Therapeutics stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
SMMT
Summit Therapeutics
healthcare
At close
$17.59
â–² +0.42 (+2.45%)
Oct 9, 4:00 PM ET
After-hours
$17.55
â–¼ -0.04 (-0.23%)
Oct 9, 7:58 PM ET
Market Cap
$13.73B
P/E Ratio
—
1Y Return
-22.34%
EPS (TTM)
-$1.12
Read the latest TheStreet Pro articles mentioning Summit Therapeutics, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning SMMT yet.
Daily Diary Mentions
1 mentionSelect Premarket Movers